13D Filing: Versant Venture Capital IV, L.P. and Crispr Therapeutics AG (CRSP)

Page 14 of 18

Page 14 of 18 – SEC Filing

 

Item 7.               Materials to be Filed as Exhibits.

 

Exhibit 1:

 

Joint Filing Agreement as required by Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended

 

14


Follow Crispr Therapeutics Ag (NASDAQ:CRSP)

Page 14 of 18